previous compound ID: 801 next compound
InChIKey: HBOMLICNUCNMMY-XLPZGREQSA-N
SMILES: CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-]

biological descriptors:

CFTR relevance: weak CFTR corrector

Category:
Influence on CFTR function enhances CFTR function
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 55
"D Zhang" "GW Carlile" "Y Luo" "JW Hanrahan" "R Robert" "KA Teske" "DY Thomas"

chemical graph of compound 801





CID is 35370
synonyms found at PubChem are:
zidovudine, Azidothymidine, 30516-87-1, Retrovir, 3'-Azido-3'-deoxythymidine, AZT, Zidovudinum, Compound S, Thymidine, 3'-azido-3'-deoxy-, BW A509U, zidovudin, Zidovudinum [Latin], Zidovudina, Aztec, Zidovudina [Spanish], AZT Antiviral, AZT, Antiviral, ZIDOVUDINE [AZT], AZT (Antiviral), BWA509U, Apo-Zidovudine, BW-A 509U, Novo-Azt, Propolis+AZT, azidodeoxythymidine, 3'-Azido-2',3'-Dideoxythymidine, DRG-0004, Retrovir(TM), AZT & Li & EPO, ZDV, UNII-4B9XT59T7S, Retrovir (TN), 3'-Deoxy-3'-azidothymidine, CCRIS 105, Zidovudine EP III, Cpd S, BW-A509U, BWA-509U, Intron A & AZT, Racemic Liposomal AZT, BW-A-509U, HSDB 6515, Liposomal AZT-SN-1, Liposomal AZT-SN-3, Zidovudine+PRO 140, Zidovudine [USAN:INN:BAN:JAN], PC-SOD+AZT, AZT & srCD4, AZT & rIFN.alpha.2, AZT & rsT4, rIFN-beta seron & AZT, 3-Azido-3-deoxythymidine, 3'-Azido-3'-deoxythymidine (AIDS), AZT & EPO, AZT & GM-CSF, AZT & HPA, AZT & sCD4, AZT & SST, CHEMBL129, NSC 602670, AZT & Li & GM-CSF, AZT+PRO 140, Met-SDF-1.beta. & AZT, AZT & Li & IL-1, AZT & Li & IL-6, MLS000028548, 4B9XT59T7S, AZT & IL-1, AZT & IL-2, AZT & IL-6, AZT & Interferon-.alpha.-2, 1-((2R,4S,5S)-4-AZIDO-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-5-METHYLPYRIMIDINE-2,4(1H,3H)-DIONE, 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione, AZT & Concanavalin A (ConA), AZT & Lymphoblastoid Interferon, AZT & PM-19, CHEBI:10110, Met-SDF-1.beta. & Zidovudine, AZT & rsCD4 & rIFN.alpha.A, HBOMLICNUCNMMY-XLPZGREQSA-N, 3'-azido-3'-deoxythymidine, AZT, DS-4152 & AZT, AZT & Colony-stimulating factor 2, AZT & NP (from PHCA or HSA), K7 [P Ti2 W10 O40], 3′-Azido-3′-deoxythymidine, NCGC00023945-05, AZT & CD4(178)-PE 40, SMR000058351, DSSTox_CID_127, 3'-Azido-3'-deoxythymidine & Erythropoietin, 3'-Azido-3'-deoxythymidine & Sho-Saiko-To, Interferon AD + 3'-azido-3'-deoxythymidine, 3'-Azido-3'-deoxythymidine & Concanavalin A, 3'-Azido-3'-deoxythymidine & Interleukin-1, 3'-Azido-3'-deoxythymidine & Interleukin-2, 3'-Azido-3'-deoxythymidine & Interleukin-6, AZT TRANSPLACENTAL CARCINOGENESIS STUDY, 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)-5-methylpyrimidine-2,4-(1H,3H)-dione, DSSTox_RID_75386, DSSTox_GSID_20127, Azitidin, 399024-19-2, 1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine, 3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin, 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1, 3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6, 3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon, SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle), SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle), 3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19, racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle), Antiviral AZT, ZVD, zudovidine, 3' Azido 3' deoxythymidine, Dendrigen, BWA 509U, 4lhm, 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (AZT), 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione [AZT], 3&prime, Retrovis (TN), 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione, 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione, 3' Azido 2',3' Dideoxythymidine, 3''-azido-thymidine, AZT & IFN-alpha, Zidovudine [USAN:USP:INN:BAN:JAN], Zidovudine & IFNL1, Zidovudine & IFNL2, Zidovudine & IFNL3, Zidovudine (Retrovir), Spectrum_001348, AZT & IFN.alpha., Zidovudine & IL-29, Zidovudine & IL-28A, Zidovudine & IL-28B, AC1L1TKL, AC1Q2OEK, AZT & Interleukin 29, Opera_ID_1602, Prestwick3_000333, Spectrum2_000927, Spectrum3_001507, Spectrum4_000332, Spectrum5_001101, 3'azido-3'deoxythymidine, AZT & Interleukin 28A, AZT & Interleukin 28B, D01XYJ, D0UF5H, D0YX5A, 3'-azido3'-deoxythymidine, AZT & IFNL1, AZT & IFNL2, AZT & IFNL3, Antiviral, Shanghai Genomics, AZT & Interferon lambda-1, AZT & Interferon lambda-2, AZT & Interferon lambda-3, 3''-Deoxy-3-azidothymidine, BSPBio_000365, BSPBio_003153, KBioGR_000703, KBioSS_001828, Zidovudine (JAN/USP/INN), microthornmicro feminineEthOUO, MLS001055351, MLS001076358, MLS002153202, MLS002222249, Zidovudine & Interleukin 29, DivK1c_000524, SPECTRUM1502109, 3'-deoxy-3'-azido-thymidine, SPBio_000834, Zidovudine & Interleukin 28A, Zidovudine & Interleukin 28B, AZT & IL-28A, AZT & IL-28B, BPBio1_000403, GTPL4825, Zidovudine (JP17/USP/INN), DTXSID8020127, SCHEMBL14615088, AZT & IL-29, CTCE-0422, CTK4I2082, HMS501K06, KBio1_000524, KBio2_001828, KBio2_004396, KBio2_006964, KBio3_002653, KS-00000WOF, Antiviral, Chemokine Therapeutics, 3''-Azido-3''-deoxy-thymidine, MolPort-002-507-286, NINDS_000524, Zidovudine & Interferon lambda-1, Zidovudine & Interferon lambda-2, Zidovudine & Interferon lambda-3, HMS1921J20, HMS2090G11, HMS2092D06, HMS2096C07, HMS2234K17, HMS3259H17, HMS3713C07, Pharmakon1600-01502109, 1-((2R,4R,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, ZINC3779042, 3''azido-2''3''-dideoxythymidine, Tox21_110062, Tox21_110894, Tox21_202203, Tox21_300578, AEe paragraph signa.o paragraph sign, ANW-26899, BBL033764, BDBM50002692, CCG-39924, CZ0012, MFCD00006536, NSC758185, STK801891, AKOS005622576, AKOS015842610, Tox21_110062_1, 3''-azido-2'',3''-dideoxythymidine, DB00495, Flt3 ligand (viral infection) Shanghai, LS-1159, MCULE-8664408343, NC00666, NSC-758185, IDI1_000524, NCGC00014918-01, NCGC00023945-03, NCGC00023945-04, NCGC00023945-06, NCGC00023945-07, NCGC00023945-08, NCGC00023945-09, NCGC00023945-10, NCGC00023945-12, NCGC00023945-13, NCGC00178237-01, NCGC00178237-02, NCGC00254276-01, NCGC00259752-01, AS-13019, CPD000058351, SAM002548971, SBI-0051731.P002, AB0012841, Immunostimulant (viral infection), Shanghai, FT-0601543, Propolis & Thymidine, 3'-azido-3'-deoxy-, S2579, 3'-Azido-3'deoxythymidine & Interferon-alpha, EN300-52518, 3'-Azido-3'-deoxythymidine, >=98% (HPLC), C07210, D00413, J10271, W-5037, 3'-Azido-3'deoxythymidine & Interferon .alpha., 3'-Azido-3'-deoxythymidine, >=99.0% (HPLC), SR-01000000098, SR-05000001587, J-700147, SR-01000000098-3, SR-05000001587-1, BRD-K72903603-001-04-6, BRD-K72903603-001-14-5, Z1723414428, Zidovudine, European Pharmacopoeia (EP) Reference Standard, 3'-Azido-3'-deoxythymidine & Recombinant Interferon-.alpha.-2, Zidovudine, United States Pharmacopeia (USP) Reference Standard, 3'-Azido-3'-deoxythymidine & CD4-Pseudomonas exotoxin A hybrid, Beta interferon(rIFN-beta seron) & 3'-Azido-3'-deoxythymidine(AZT), Lecithinized superoxide dismutase & Thymidine, 3'-azido-3'-deoxy-, 3'-Azido-2',3'-dideoxythymidine & sCD4(soluble recombinant protein), Sulfated polysaccharide-peptidoglycan DS-4152 & 3'-Azido-3'-deoxythymidine, Thymidine, 3'-azido-3'-deoxy- & PRO 140 (Anti-CCR5 monoclonal antibody), Zidovudine, Pharmaceutical Secondary Standard; Certified Reference Material, (AZT) 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione, (AZT)1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione, 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione, 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(AZT), 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione, 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione, 3'-Azido-3'-deoxythymidine & Lithium & Granulocyte-macrophage colony-stimulating factor, 3'-Azido-3'deoxythymidine & Recombinant Soluble CD4 & Recombinant Interferon.alpha.A, 4-(4-Azido-5-hydroxy-tetrahydro-furan-2-yl)-5-methyl-3H-pyrazine-2,6-dione, Met-Stromal Cell-derived Factor-1.beta. (Human) & 3'-Azido-3'-deoxythymidine, 1-((2R,4S,5S)-4-(diazoamino)-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 1-((2R,4S,5S)-4-azido-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 1-((2R,5S)-4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione, 1-((2S,4R,5R)-4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione, 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (AzddThd, AZT), 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (N3ddThd), 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(3''-azido-2'',3''-dideoxythymidine), 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(azidothymidine, AZT), 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(Zidovudine, AZT), 3'-Azido-3'deoxythymidine & Nanoparticles (from human serum albumin or polyhexylcyanoacrylate), 3-((2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)triaz-1-en-2-ium-1-ide, 3-Azido-1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-D-erythro- pentofuranuronic acid